Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
Clinical trial NCT02917096 · COMPLETED
Trial details
- NCT number
- NCT02917096
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-13
- Primary completion
- 2020-04-16
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.